Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1

Grants

Funding Acknowledgements

We wish to thank all individuals in the respective cohorts for their generous participation. This work was supported by the Wellcome Trust (grant number WT089062) and, among others, by the Academy of Finland (200923 to AP, 00213 to M. W.); the Helsinki University Central Hospital (to M. Kallela., M. F., V. Artto and S. V.); the Academy of Finland Center of Excellence for Complex Disease Genetics; the EuroHead project (LSM-CT-2004-504837); the Helsinki Biomedical Graduate School (to V. Anttila, P. T.-K.); the Finnish Cultural Foundation (to V. Anttila); the Finnish Neurology Foundation, Biomedicum Helsinki Foundation (to V. Anttila, P. T.-K. and V. Artto); the Cambridge Biomedical Research Centre (to S. C.); the Australian National Health and Medical Research Council Fellowship (339462 and 613674) and the Australian Research Council Future Fellowship (FT0991022) schemes (to D. R. N.); the German Federal Ministry of Education and Research (BMBF) (grant 01GS08121 to M. Dichgans, along with support to H. E. W. in the context of the German National Genome Research Network (NGFN-2 and NGFN-plus) for the Heinz Nixdorf Recall study, and to C. K. (EMINet -01GS08120) for the National Genome Research Network (Germany; NGFN-1 and NGFN-Plus)); the Center for Molecular Medicine Cologne (to C. K.); the Heinz Nixdorf Foundation for the Heinz Nixdorf Recall study, Deutsche Forschungsgemeinschaft (DFG; to C. K. and H. G.); the Netherlands Organization for the Health Research and Development (ZonMw) no. 90700217 (to G. M. T.) and to the Rotterdam Study (RIDE1 and RIDE2); the Netherlands Organisation for Scientific Research (NWO) VICI (918.56.602) and Spinoza (2009) grants (to M. D. F.); and the Center for Medical Systems Biology (CMSB) established by the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NGI/NWO), project no. 050-060-409 (to C. M. v. D., R. R. F., M. D. F. and A. M. J. M. v. d. M.) and project nos. 050-060-810 and 175.010.2005.011, 911-03-012 (to the Rotterdam Study). We thank the Health 2000 study for providing Finnish control genotypes. The Broad Institute Center for Genotyping and Analysis is supported by a grant from the National Center for Research Resources (US). The KORA research platform was initiated and financed by the Helmholtz Center Munich, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria and is supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII) and the Municipality of Rotterdam. We wish to thank S. Hunt, R. Gwillian, P. Whittaker, S. Potter and A. Tashakkori-Ghanbarian, as well as P. Marin-Garcia, for their invaluable help with this study. Finally, we wish to collectively thank everyone who has contributed to the collection, genotyping and analysis of the individual cohorts.